Literature DB >> 33994342

Inter-fractional variation of markers and applicators in single-implant high-dose-rate interstitial brachytherapy for gynecologic malignancies.

Mark Ostyn1, Aidan M Burke2, Emma Fields1, Dorin Todor3.   

Abstract

PURPOSE: Implanted fiducial markers are a commonly used tool in delineating the CTV in high-dose-rate interstitial brachytherapy (HDR-ISBT) for gynecologic malignancy, but their reliability in gynacological sites is not well understood. These markers and interstitial applicators can experience interfractional motion due to organ swelling or other anatomical changes. The purpose of this study was to evaluate the spatial variation of these features. METHODS AND MATERIALS: The spatial positions of 50 implanted markers and 202 needles were tracked in 15 patients treated over 70 fractions of HDR brachytherapy. Marker and/or needle coordinates were extracted from CT images with contours and dose distributions. Automated analysis determined marker self-consistency and displacements between various elements of the implant.
RESULTS: From start to end fraction, the relative positions of the markers experienced an average magnitude displacement of 4.5 ± 3.0 mm while the average displacement of the applicator tips was 11 ± 8 mm, relative to their respective centers of mass (CM).
CONCLUSIONS: Markers implanted lateral and superior to the CTV experience greater drift than other implant locations.
Copyright © 2021 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brachytherapy; Fiducial markers; Gynecological cancers; HDR

Year:  2021        PMID: 33994342     DOI: 10.1016/j.brachy.2021.03.011

Source DB:  PubMed          Journal:  Brachytherapy        ISSN: 1538-4721            Impact factor:   2.362


  3 in total

1.  High-dose-rate brachytherapy boost for locally advanced cervical cancer: Oncological outcome and toxicity analysis of 4 fractionation schemes.

Authors:  Maud le Guyader; Daniel Lam Cham Kee; Brice Thamphya; Renaud Schiappa; Mathieu Gautier; Marie-Eve Chand-Fouche; Jean-Michel Hannoun-Levi
Journal:  Clin Transl Radiat Oncol       Date:  2021-11-06

2.  Proton Arc Therapy vs Interstitial HDR Brachytherapy in Gynecologic Cancer with Parametrial/pelvic Side Wall Extension.

Authors:  ByongYong Yi; Sina Mossahebi; Arezoo Modiri; Elizabeth M Nichols; Mariana Guerrero; Narottam Lamichhane; Pranshu Mohindra
Journal:  Int J Part Ther       Date:  2022-06-28

3.  Comparison of the Dosimetric Influence of Applicator Displacement on 2D and 3D Brachytherapy for Cervical Cancer Treatment.

Authors:  Ailin Wu; Du Tang; Aidong Wu; Yunqin Liu; Liting Qian; Lei Zhu
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.